SG3 Management’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
Other funds holding TAK
PPA
MIP
BIP
SG3 Management's TAK Position: Q1 2022 in Review
SG3 Management sold out of Takeda Pharmaceutical (TAK) in Q1 2022, closing a stake of 25,000 shares — an estimated $341K sold.
SG3 Management first reported a position in TAK in Q1 2019 and held it in 2 quarters. The position peaked at $2.27M in Q1 2019. 287 funds tracked by Wall St. Rank hold TAK as of Q1 2022.
- SG3 Management reported no remaining Takeda Pharmaceutical position as of Q1 2022 after selling out during the quarter.
- SG3 Management sold 25,000 Takeda Pharmaceutical shares in Q1 2022, an estimated $341K.
- SG3 Management first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 2 quarters.
- SG3 Management's Takeda Pharmaceutical position peaked at $2.27M in Q1 2019.
- 287 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2022.
Based on SG3 Management's 13F filing for Q1 2022, filed 16 May 2022.